Localized Oesogastric Adenocarcimona

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Localized Oesogastric Adenocarcimona trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 2

NCT04006262

Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.

This is a non-randomized study, open label phase II study. The purpose of this study is to evaluate the complete pathologic response rate (cPRR) with neoadjuvan…

France32 participantsStarted 2019-10-23

Treatment: Nivolumab 10 MG/ML, Ipilimumab 200 MG in 40 ML Injection